Celanese (NYSE: CE) announced a $0.03 quarterly dividend and targeted price increases of $50–$100/MT across key acetate and ester product lines in the Americas. Those concrete moves aim to offset elevated feedstock costs and shore up margins as specialty-chemical peers face persistent EBITDA pressure and rising leverage. The actions are a clear signal of pricing power and capital-allocation discipline for S&P 500-listed Celanese.
Chemours (CC) recently hit an RS Rating of 83 and broke above a 16.58 handle, sparking a >5% move. With Q4 2025 results scheduled for Feb 19–20, 2026 and recent weak fundamentals, investors face a tension between technical momentum and operational headwinds.
